Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Isolated and Skeptical: Social Engagement and Trust in Information Sources Among Smokers
  2. Rutten, L. J. F.; Blake, K.; Hesse, B. W.; Ackerson, L. K.
  3. Journal of Cancer Education. 2011, Sep; 26(3): 465-473.
  1. 2.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 3.   Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging
  2. Jansen, S. A.
  3. Seminars in Ultrasound Ct and Mri. 2011, Aug; 32(4): 306-318.
  1. 4.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 5.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 6.   ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION
  2. Beigel, J. H.
  3. Drugs of the Future. 2010, May; 35(5): 385-392.
  1. 7.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 8.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 9.   The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness
  2. Healey, L. M.; Hahn, B. K.; Rehm, C. A.; Adelsberger, J.; Qin, J.; Follmann, D. A.; Tavel, J.; Kovacs, J. A.; Sereti, I.; Davey, R. T.
  3. Journal of Interferon and Cytokine Research. 2008 28(7): 455-461.
  1. 10.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 11.   CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
  2. Read, S. W.; Lempicki, R. A.; Di Mascio, M.; Srinivasula, S.; Burke, R.; Sachau, W.; Bosche, M.; Adelsberger, J. W.; Sereti, I.; Davey, R. T.; Tavel, J. A.; Huang, C. Y.; Issaq, H. J.; Fox, S. D.; Lane, H. C.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(6): 843-850.
  1. 12.   Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
  2. Garcia-Pineres, A.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Williams, M.; Harro, C.; Lowy, D. R.; Schiller, J. T.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2007, Aug; 14(8): 984-989.
  1. 13.   Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan
  2. Roberts, J. N.; Buck, C. B.; Thompson, C. D.; Kines, R.; Bernardo, M.; Choyke, P. L.; Lowy, D. R.; Schiller, J. T.
  3. Nature Medicine. 2007, Jul; 13(7): 857-861.
  1. 14.   Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: Interferon induces HR independent of sustained virologic response (SVR)
  2. Wu, L.; Kottilil, S.; Lempicki, R.; Yang, J.; McLaughlin, M.; Hu, Z. H.; Koratich, C.; Reitano, K. N.; Rehm, C. A.; Masur, H.; Wood, B.; Kleiner, D. E.; Polis, M. A.
  3. Aids Research and Human Retroviruses. 2006, Nov; 22(11): 1091-1098.
  1. 15.   Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles
  2. Pinto, L. A.; Viscidi, R.; Harro, C. D.; Kemp, T. J.; Garcia-Pineres, A. J.; Trivett, M.; Demuth, F.; Lowy, D. R.; Schiller, J. T.; Berzofsky, J. A.; Hildesheim, A.
  3. Virology. 2006, Sep; 353(2): 451-462.
  1. 16.   Stem cells in prostate cancer - Resolving the castrate-resistant conundrum and implications for hormonal therapy
  2. Sharifi, N.; Kawasaki, B. I.; Hurt, E. M.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2006, Aug; 5(8): 901-906.
  1. 17.   Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE
  2. Chen, X.; Oppenheim, J. J.; Winkler-Pickett, R. T.; Ortaldo, J. R.; Howard, O. M. Z.
  3. European Journal of Immunology. 2006, Aug; 36(8): 2139-2149.
  1. 18.   In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories
  2. Beer, B. E.; Doncel, G. F.; Krebs, F. C.; Shattock, R. J.; Fletcher, P. S.; Buckheit, R. W.; Watson, K.; Dezzutti, C. S.; Cummins, J. E.; Bromley, E.; Richardson-Harman, N.; Pallansch, L. A.; Lackman-Smith, C.; Osterling, C.; Mankowski, M.; Miller, S. R.; Catalone, B. J.; Welsh, P. A.; Howett, M. K.; Wigdahl, B.; Turpin, J. A.; Reichelderfer, P.
  3. Antimicrobial Agents and Chemotherapy. 2006, Feb; 50(2): 713-723.
  1. 19.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 20.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 21.   Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA)
  2. Polianova, M. T.; Ruscetti, F. W.; Pert, C. B.; Tractenberg, R. E.; Leoung, G.; Strang, S.; Ruff, M. R.
  3. Peptides. 2003 24(7): 1093-1098.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel